연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
1767. Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single Institute.
Choi Y1, Keam B1,2, Kim TM1,2, Lee SH1,2, Kim DW1,2, Heo DS1,2.
Cancer Res Treat. 2015 Oct;47(4):555-63. doi: 10.4143/crt.2014.200. Epub 2015 Feb 16.
Link
1766. The Clinical Significance and Molecular Features of the Spatial Tumor Shapes in Breast Cancers.
Moon HG, Kim N, Jeong S, Lee M, Moon H, Kim J, Yoo TK, Lee HB, Kim J, Noh DY, Han W.
PLoS One. 2015;10(12):e0143811. doi: 10.1371/journal.pone.0143811.
Link
1765. In Vivo Tumor Growth Rate Measured by US in Preoperative Period and Long Term Disease Outcome in Breast Cancer Patients.
Yoo TK, Min JW, Kim MK, Lee E, Kim J, Lee HB, Kang YJ, Kim YG, Moon HG, Moon WK, Cho N, Noh DY, Han W.
PLoS One. 2015;10(12):e0144144. doi: 10.1371/journal.pone.0144144.
Link
1764. Metformin intervention in obese non-diabetic patients with breast cancer: phase II randomized, double-blind, placebo-controlled trial.
Ko KP, Ma SH, Yang JJ, Hwang Y, Ahn C, Cho YM, Noh DY, Park BJ, Han W, Park SK.
Breast Cancer Res Treat. 2015 Sep;153(2):361-70. doi: 10.1007/s10549-015-3519-8. Epub 2015 Aug 21.
Link
1763. Impact of Chemotherapy-Induced Ovarian Dysfunction on Response to Neoadjuvant Chemotherapy in Breast Cancer.
Ahn SK, Lee HB, Han W, Moon HG, You JM, Kim J, Han SW, Im SA, Kim TY, Noh DY.
Ann Surg Oncol. 2015 Dec;22 Suppl 3:391-7. doi: 10.1245/s10434-015-4806-7. Epub 2015 Aug 15.
Link
1762. Recurrent fusion transcripts detected by whole-transcriptome sequencing of 120 primary breast cancer samples.
Kim J, Kim S, Ko S, In YH, Moon HG, Ahn SK, Kim MK, Lee M, Hwang JH, Ju YS, Kim JI, Noh DY, Kim S, Park JH, Rhee H, Kim S, Han W.
Genes Chromosomes Cancer. 2015 Nov;54(11):681-91. doi: 10.1002/gcc.22279. Epub 2015 Jul 30.
Link
1761. Risk Factors Associated with Distant Metastasis and Survival Outcomes in Breast Cancer Patients with Locoregional Recurrence.
Park S, Han W, Kim J, Kim MK, Lee E, Yoo TK, Lee HB, Kang YJ, Kim YG, Moon HG, Noh DY.
J Breast Cancer. 2015 Jun;18(2):160-6. doi: 10.4048/jbc.2015.18.2.160. Epub 2015 Jun 26.
Link
1760. Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer.
Kim T, Han W, Kim MK, Lee JW, Kim J, Ahn SK, Lee HB, Moon HG, Lee KH, Kim TY, Han SW, Im SA, Park IA, Kim JY, Noh DY.
J Breast Cancer. 2015 Mar;18(1):16-21. doi: 10.4048/jbc.2015.18.1.16. Epub 2015 Mar 27.
Link
1759. Different prognostic effect of CpG island methylation
according to sex in colorectal cancer patients treated with adjuvant FOLFOX
Lee DW, Han SW*, Cha Y, Rhee YY, Bae JM, Cho NY, Lee KH, Kim TY, Oh DY, Im SA,
Bang YJ, Jeong SY, Park KJ, Kang GH, Kim TY
Clin Epigenetics.
2015;7(1):63.
Link
1758. Clinical Implication of Anti-Angiogenic Effect of Regorafenib in Metastatic Colorectal Cancer.
Lim Y, Han SW, Yoon JH, Lee JM, Lee JM, Paeng JC, Won JK, Kang GH, Jeong SY, Park KJ, Lee KH, Kim JH, Kim TY.
PLoS One 2015 Dec 15;10(12):e0145004.
Link